| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | NOVAVAX INC COM | 25,787 | 54,000 | 0.03% | ||
| 2 | SERES THERAPEUTICS INC | 14,000 | 172,000 | 0.10% | ||
| 3 | GRIFOLS S A SP ADR REP B | 11,849 | 189,000 | 0.11% | ||
| 4 | LION BIOTECHNOLOGIES INC COM | 23,594 | 194,000 | 0.11% | ||
| 5 | NEUROCRINE BIOSCIE COM USD0.001 | 4,068 | 206,000 | 0.12% | ||
| 6 | JUNO THERAPEUTICS INC COM | 6,918 | 208,000 | 0.12% | ||
| 7 | Axovant Sciences LTD | 14,844 | 208,000 | 0.12% | ||
| 8 | UNITED THERAPEUTICS CORP DEL | 1,768 | 209,000 | 0.12% | ||
| 9 | INTERCEPT PHARMACEUTICALS INCORPORATED | 1,306 | 215,000 | 0.12% | ||
| 10 | QUINTILES IMS HOLDINGS INC | 2,730 | 221,000 | 0.12% | ||
| 11 | OPHTHOTECH CORP | 6,746 | 311,000 | 0.17% | ||
| 12 | DEPHEID | 5,985 | 315,000 | 0.18% | ||
| 13 | ULTRAGENYX PHARMACEUTICAL INC COM | 7,074 | 502,000 | 0.28% | ||
| 14 | PORTOLA PHARMACEUTICALS INC | 25,000 | 568,000 | 0.32% | ||
| 15 | PROSHARES TR | 40,000 | 656,000 | 0.37% | ||
| 16 | DIREXION PORTFOLIOPLUS SP BIOTCH BL NEW ETF | 14,640 | 714,000 | 0.40% | ||
| 17 | CONTRAFECT CORP COM | 300,000 | 744,000 | 0.42% | ||
| 18 | NEW SR INVEST GRP INC COM | 83,700 | 966,000 | 0.54% | ||
| 19 | ADAMAS PHARMACEUTICALS INC | 60,000 | 985,000 | 0.55% | ||
| 20 | PARATEK PHARMACEUTICALS INC | 80,000 | 1,041,000 | 0.58% | ||
| 21 | MEDICINES CO | 28,000 | 1,057,000 | 0.59% | ||
| 22 | PACIRA PHARMACEUTICALS INC | 50,000 | 1,711,000 | 0.96% | ||
| 23 | BRISTOL MYERS SQUIBB CO | 45,000 | 2,426,000 | 1.36% | Call | |
| 24 | GLAXOSMITHKLINE PLC | 60,000 | 2,588,000 | 1.45% | ||
| 25 | IONIS PHARMACEUTICALS INC COM | 76,439 | 2,801,000 | 1.57% | ||
| 26 | VERTEX PHARMACEUTICALS INC | 32,141 | 2,803,000 | 1.57% | ||
| 27 | CELGENE CORP | 26,859 | 2,808,000 | 1.57% | ||
| 28 | BIOMARIN PHARMACEUTICAL INC | 30,639 | 2,835,000 | 1.59% | ||
| 29 | AGIOS PHARMACEUTICALS INC | 54,692 | 2,889,000 | 1.62% | ||
| 30 | ALEXION PHARMACEUTIC | 24,571 | 3,011,000 | 1.69% | ||
| 31 | METTLER-TOLEDO | 7,188 | 3,018,000 | 1.69% | ||
| 32 | REGENERON PHARMACEUTICALS | 7,512 | 3,020,000 | 1.69% | ||
| 33 | NEKTAR THERAPEUTICS COM | 176,611 | 3,034,000 | 1.70% | ||
| 34 | QIAGEN NV | 110,565 | 3,034,000 | 1.70% | ||
| 35 | ALNYLAM PHARMACEUTICALS INC | 45,064 | 3,054,000 | 1.71% | ||
| 36 | AMGEN INC | 18,322 | 3,056,000 | 1.71% | ||
| 37 | INCYTE CORP | 34,626 | 3,265,000 | 1.83% | ||
| 38 | ILLUMINA INC | 18,400 | 3,343,000 | 1.87% | ||
| 39 | BIOGEN INC | 10,704 | 3,351,000 | 1.88% | ||
| 40 | SEATTLE GENETICS INC | 67,953 | 3,670,000 | 2.06% | ||
| 41 | PFIZER INC | 112,300 | 3,804,000 | 2.13% | ||
| 42 | ALKERMES PLC | 81,677 | 3,841,000 | 2.15% | ||
| 43 | ASTRAZENECA PLC | 120,000 | 3,943,000 | 2.21% | ||
| 44 | BRISTOL MYERS SQUIBB CO | 75,686 | 4,081,000 | 2.29% | ||
| 45 | PROSHARES TR | 85,000 | 4,119,000 | 2.31% | ||
| 46 | MERCK & CO INC | 83,700 | 5,224,000 | 2.93% | ||
| 47 | ISHARES TR | 25,000 | 7,236,000 | 4.06% | ||
| 48 | SPDR SER TR | 130,000 | 8,618,000 | 4.83% | ||
| 49 | SPDR SER TR | 430,400 | 28,531,000 | 16.00% | Put | |
| 50 | ISHARES TR | 350,000 | 43,474,000 | 24.38% | Put |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001387131-16-007967, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
